stockrowBausch + Lomb Corporation
BLCO Healthcare Medical Instruments & Supplies
Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024.
- Revenue
- +7.34%
- EPS
- +222.4%
- Free cash flow
- +182.5%
- Total debt
- +2.93%
Quarter to September 2026, against a year earlier
Follow BLCO
Alert me
Bausch + Lomb Corporation (BLCO) Revenue
Bausch + Lomb Corporation's revenue for fiscal 2025 was $5.1B, up 6.47% from $4.8B in fiscal 2024. Over the twelve months to 30 September 2026 it was $5.4B. Over the past ten years it has ranged from $3.4B (fiscal 2020) to $5.1B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 5 consecutive fiscal years. Bausch + Lomb Corporation ranks 9th of 47 Medical Instruments & Supplies companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $5.1B | 6.47% |
| FY2024 | $4.8B | 15.56% |
| FY2023 | $4.1B | 10.03% |
| FY2022 | $3.8B | 0.08% |
| FY2021 | $3.8B | 10.35% |
| FY2020 | $3.4B | — |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $1.4B | (1.36%) |
| Jun 2026 | $1.4B | 12.06% |
| Mar 2026 | $1.2B | (11.46%) |
| Dec 2025 | $1.4B | 9.68% |
| 19 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| AVTR Avantor, Inc. compare | $6.6B |
| BLCO Bausch + Lomb Corporation | $5.4B |
| COO The Cooper Companies, Inc. compare | $4.2B |
| ALGN Align Technology, Inc. compare | $4.2B |
| ATR AptarGroup, Inc. compare | $4.0B |
| MMED MiniMed Group, Inc. compare | $3.0B |
| TFX Teleflex Incorporated compare | $2.3B |
| MMSI Merit Medical Systems, Inc. compare | $1.6B |
| RGEN Repligen Corporation compare | $805.6M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on BLCO
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement